JP2023540441A5 - - Google Patents
Info
- Publication number
- JP2023540441A5 JP2023540441A5 JP2023507726A JP2023507726A JP2023540441A5 JP 2023540441 A5 JP2023540441 A5 JP 2023540441A5 JP 2023507726 A JP2023507726 A JP 2023507726A JP 2023507726 A JP2023507726 A JP 2023507726A JP 2023540441 A5 JP2023540441 A5 JP 2023540441A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060353P | 2020-08-03 | 2020-08-03 | |
| US63/060,353 | 2020-08-03 | ||
| PCT/US2021/044351 WO2022031708A1 (en) | 2020-08-03 | 2021-08-03 | Aav vectors encoding parkin and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540441A JP2023540441A (ja) | 2023-09-25 |
| JP2023540441A5 true JP2023540441A5 (https=) | 2024-08-09 |
| JPWO2022031708A5 JPWO2022031708A5 (https=) | 2024-08-09 |
Family
ID=80118490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507726A Pending JP2023540441A (ja) | 2020-08-03 | 2021-08-03 | Ｐａｒｋｉｎをコードするａａｖベクターおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230304036A1 (https=) |
| EP (1) | EP4189097A4 (https=) |
| JP (1) | JP2023540441A (https=) |
| KR (1) | KR20230043181A (https=) |
| CN (1) | CN116113701A (https=) |
| AU (1) | AU2021322113A1 (https=) |
| BR (1) | BR112023001788A2 (https=) |
| CA (1) | CA3190720A1 (https=) |
| IL (1) | IL300219A (https=) |
| MX (1) | MX2023001565A (https=) |
| WO (1) | WO2022031708A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1504108B1 (en) * | 2002-02-01 | 2013-04-17 | Oxford Biomedica (UK) Limited | Lentiviral vector |
| AU2013243948A1 (en) * | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins associated with human disease |
| EP3452101A2 (en) * | 2016-05-04 | 2019-03-13 | CureVac AG | Rna encoding a therapeutic protein |
| WO2018209126A1 (en) * | 2017-05-10 | 2018-11-15 | Rowan University | Diagnostic biomarkers for detecting, subtyping, and/or assessing progression of multiple sclerosis |
| KR102709597B1 (ko) * | 2017-10-03 | 2024-09-26 | 프리베일 테라퓨틱스, 인크. | 리소좀 장애를 위한 유전자 요법 |
| CA3096293A1 (en) * | 2018-04-27 | 2019-10-31 | Rocket Pharmaceuticals, Ltd. | Gene therapy for cns degeneration |
-
2021
- 2021-08-03 CA CA3190720A patent/CA3190720A1/en active Pending
- 2021-08-03 IL IL300219A patent/IL300219A/en unknown
- 2021-08-03 BR BR112023001788A patent/BR112023001788A2/pt unknown
- 2021-08-03 KR KR1020237006437A patent/KR20230043181A/ko not_active Withdrawn
- 2021-08-03 EP EP21852310.8A patent/EP4189097A4/en not_active Withdrawn
- 2021-08-03 WO PCT/US2021/044351 patent/WO2022031708A1/en not_active Ceased
- 2021-08-03 AU AU2021322113A patent/AU2021322113A1/en active Pending
- 2021-08-03 MX MX2023001565A patent/MX2023001565A/es unknown
- 2021-08-03 US US18/019,357 patent/US20230304036A1/en active Pending
- 2021-08-03 CN CN202180057979.4A patent/CN116113701A/zh active Pending
- 2021-08-03 JP JP2023507726A patent/JP2023540441A/ja active Pending